Effect of short-term GnRH pulse therapy on pituitary-testicular function in adolescent male patients with congenital hypogonadotropic hypogonadism

Objective·To investigate the effect of short-term gonadotropin-releasing hormone (GnRH) pulse therapy on pituitary and testicular function in the adolescent male patients with congenital hypogonadotropic hypogonadism (CHH).Methods·A retrospective study was conducted on 20 adolescent male patients wi...

Full description

Bibliographic Details
Main Authors: WANG Fei, GONG Yan, XU Liya, LIU Qingxu, LI Yan, GUO Sheng, LI Pin
Format: Article
Language:zho
Published: Editorial Office of Journal of Shanghai Jiao Tong University (Medical Science) 2023-01-01
Series:Shanghai Jiaotong Daxue xuebao. Yixue ban
Subjects:
Online Access:https://xuebao.shsmu.edu.cn/article/2023/1674-8115/1674-8115-2023-43-1-36.shtml
_version_ 1797392981272035328
author WANG Fei
GONG Yan
XU Liya
LIU Qingxu
LI Yan
GUO Sheng
LI Pin
author_facet WANG Fei
GONG Yan
XU Liya
LIU Qingxu
LI Yan
GUO Sheng
LI Pin
author_sort WANG Fei
collection DOAJ
description Objective·To investigate the effect of short-term gonadotropin-releasing hormone (GnRH) pulse therapy on pituitary and testicular function in the adolescent male patients with congenital hypogonadotropic hypogonadism (CHH).Methods·A retrospective study was conducted on 20 adolescent male patients with CHH who received GnRH pulse therapy from January 2016 to June 2021, and their clinical data were collected. They were treated with subcutaneous continuous pulsed administration of gonadorelin by the pump for 1 week (20 cases), of which 5 cases were treated for 3 months. The dose was 8‒10 μg per pulse, and the pulse interval was 90 min. The levels of luteinizing hormone (LH), follicle stimulating hormone (FSH) and testosterone were measured before GnRH pulse therapy at 1 week, 1 month and 3 months after treatment. After 3 months of treatment, the testicular volume was measured. All 20 patients with CHH underwent whole exome sequencing.Results·The age of 20 CHH patients was 14.35 (14.08, 15.31) years old. The clinical manifestations were infantile testis (20/20) and micropenis (20/20), followed by obesity (12/20), dysosmia (9/20), insulin resistance (4/20), cryptorchidism (4/20), and short stature (3/20). The patients' height was 161.79 (154.90, 173.25) cm, body mass index was 23.80 (20.51, 27.46) kg/m2, and testicular volume was 0.91 (0.55, 1.25) mL. Inhibin B was 39.67 (11.29, 64.97) pg/mL; the base values of LH, FSH and testosterone before therapy were 0.20 (0.10, 0.30) IU/L, 0.87 (0.23, 0.89) IU/L, and 0.92 (0.38, 1.49) nmol/L, respectively. After 1 week of continuous GnRH pulse therapy, the base and peak values of LH and FSH and the peak value of testosterone in the 20 patients significantly increased (all P<0.05). In the 5 patients treated for 3 months, the base values and peak values of LH and FSH gradually increased with the prolongation of treatment time. After 3 months of treatment, the base values and peak values of LH and FSH, and the peak value of testosterone were significantly higher than those before treatment (all P<0.05), and the testicular volume was also significantly increased (P=0.004). Gene mutations were detected in only 14 of 20 patients, including fibroblast growth factor receptor 1 (FGFR1) mutations in 7 cases, anosmin 1 (ANOS1) mutations in 4 cases, prokineticin receptor 2 (PROKR2) mutations in 2 cases, and a prokineticin 2 (PROK2) mutation in 1 case. There was no significant difference of the effect of GnRH pulse therapy for 1 week on pituitary-testicular function between the patients with FGFR1 mutations and ANOS1 mutations.Conclusion·The continuous GnRH pulse therapy for 1 week can make pituitary-testicular function respond in adolescent male CHH patients; the treatment for 3 months helps to induce the secondary sexual characteristics of puberty.
first_indexed 2024-03-08T23:56:30Z
format Article
id doaj.art-2bc07ad5e1ca434cb9b6e80db5794ce9
institution Directory Open Access Journal
issn 1674-8115
language zho
last_indexed 2024-03-08T23:56:30Z
publishDate 2023-01-01
publisher Editorial Office of Journal of Shanghai Jiao Tong University (Medical Science)
record_format Article
series Shanghai Jiaotong Daxue xuebao. Yixue ban
spelling doaj.art-2bc07ad5e1ca434cb9b6e80db5794ce92023-12-13T03:32:52ZzhoEditorial Office of Journal of Shanghai Jiao Tong University (Medical Science)Shanghai Jiaotong Daxue xuebao. Yixue ban1674-81152023-01-01431364310.3969/j.issn.1674-8115.2023.01.0051674-8115(2023)01-0036-08Effect of short-term GnRH pulse therapy on pituitary-testicular function in adolescent male patients with congenital hypogonadotropic hypogonadismWANG FeiGONG YanXU LiyaLIU QingxuLI YanGUO ShengLI PinObjective·To investigate the effect of short-term gonadotropin-releasing hormone (GnRH) pulse therapy on pituitary and testicular function in the adolescent male patients with congenital hypogonadotropic hypogonadism (CHH).Methods·A retrospective study was conducted on 20 adolescent male patients with CHH who received GnRH pulse therapy from January 2016 to June 2021, and their clinical data were collected. They were treated with subcutaneous continuous pulsed administration of gonadorelin by the pump for 1 week (20 cases), of which 5 cases were treated for 3 months. The dose was 8‒10 μg per pulse, and the pulse interval was 90 min. The levels of luteinizing hormone (LH), follicle stimulating hormone (FSH) and testosterone were measured before GnRH pulse therapy at 1 week, 1 month and 3 months after treatment. After 3 months of treatment, the testicular volume was measured. All 20 patients with CHH underwent whole exome sequencing.Results·The age of 20 CHH patients was 14.35 (14.08, 15.31) years old. The clinical manifestations were infantile testis (20/20) and micropenis (20/20), followed by obesity (12/20), dysosmia (9/20), insulin resistance (4/20), cryptorchidism (4/20), and short stature (3/20). The patients' height was 161.79 (154.90, 173.25) cm, body mass index was 23.80 (20.51, 27.46) kg/m2, and testicular volume was 0.91 (0.55, 1.25) mL. Inhibin B was 39.67 (11.29, 64.97) pg/mL; the base values of LH, FSH and testosterone before therapy were 0.20 (0.10, 0.30) IU/L, 0.87 (0.23, 0.89) IU/L, and 0.92 (0.38, 1.49) nmol/L, respectively. After 1 week of continuous GnRH pulse therapy, the base and peak values of LH and FSH and the peak value of testosterone in the 20 patients significantly increased (all P<0.05). In the 5 patients treated for 3 months, the base values and peak values of LH and FSH gradually increased with the prolongation of treatment time. After 3 months of treatment, the base values and peak values of LH and FSH, and the peak value of testosterone were significantly higher than those before treatment (all P<0.05), and the testicular volume was also significantly increased (P=0.004). Gene mutations were detected in only 14 of 20 patients, including fibroblast growth factor receptor 1 (FGFR1) mutations in 7 cases, anosmin 1 (ANOS1) mutations in 4 cases, prokineticin receptor 2 (PROKR2) mutations in 2 cases, and a prokineticin 2 (PROK2) mutation in 1 case. There was no significant difference of the effect of GnRH pulse therapy for 1 week on pituitary-testicular function between the patients with FGFR1 mutations and ANOS1 mutations.Conclusion·The continuous GnRH pulse therapy for 1 week can make pituitary-testicular function respond in adolescent male CHH patients; the treatment for 3 months helps to induce the secondary sexual characteristics of puberty.https://xuebao.shsmu.edu.cn/article/2023/1674-8115/1674-8115-2023-43-1-36.shtmlhypogonadotropic hypogonadismgonadotropin-releasing hormone (gnrh)pulse therapyadolescent
spellingShingle WANG Fei
GONG Yan
XU Liya
LIU Qingxu
LI Yan
GUO Sheng
LI Pin
Effect of short-term GnRH pulse therapy on pituitary-testicular function in adolescent male patients with congenital hypogonadotropic hypogonadism
Shanghai Jiaotong Daxue xuebao. Yixue ban
hypogonadotropic hypogonadism
gonadotropin-releasing hormone (gnrh)
pulse therapy
adolescent
title Effect of short-term GnRH pulse therapy on pituitary-testicular function in adolescent male patients with congenital hypogonadotropic hypogonadism
title_full Effect of short-term GnRH pulse therapy on pituitary-testicular function in adolescent male patients with congenital hypogonadotropic hypogonadism
title_fullStr Effect of short-term GnRH pulse therapy on pituitary-testicular function in adolescent male patients with congenital hypogonadotropic hypogonadism
title_full_unstemmed Effect of short-term GnRH pulse therapy on pituitary-testicular function in adolescent male patients with congenital hypogonadotropic hypogonadism
title_short Effect of short-term GnRH pulse therapy on pituitary-testicular function in adolescent male patients with congenital hypogonadotropic hypogonadism
title_sort effect of short term gnrh pulse therapy on pituitary testicular function in adolescent male patients with congenital hypogonadotropic hypogonadism
topic hypogonadotropic hypogonadism
gonadotropin-releasing hormone (gnrh)
pulse therapy
adolescent
url https://xuebao.shsmu.edu.cn/article/2023/1674-8115/1674-8115-2023-43-1-36.shtml
work_keys_str_mv AT wangfei effectofshorttermgnrhpulsetherapyonpituitarytesticularfunctioninadolescentmalepatientswithcongenitalhypogonadotropichypogonadism
AT gongyan effectofshorttermgnrhpulsetherapyonpituitarytesticularfunctioninadolescentmalepatientswithcongenitalhypogonadotropichypogonadism
AT xuliya effectofshorttermgnrhpulsetherapyonpituitarytesticularfunctioninadolescentmalepatientswithcongenitalhypogonadotropichypogonadism
AT liuqingxu effectofshorttermgnrhpulsetherapyonpituitarytesticularfunctioninadolescentmalepatientswithcongenitalhypogonadotropichypogonadism
AT liyan effectofshorttermgnrhpulsetherapyonpituitarytesticularfunctioninadolescentmalepatientswithcongenitalhypogonadotropichypogonadism
AT guosheng effectofshorttermgnrhpulsetherapyonpituitarytesticularfunctioninadolescentmalepatientswithcongenitalhypogonadotropichypogonadism
AT lipin effectofshorttermgnrhpulsetherapyonpituitarytesticularfunctioninadolescentmalepatientswithcongenitalhypogonadotropichypogonadism